Establishment of an EBV‐positive lymphoblastoid cell line that grows as a lymphoma in nude mice and expresses membrane CD2 molecules
- 15 February 1990
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 45 (2) , 299-307
- https://doi.org/10.1002/ijc.2910450216
Abstract
We describe a human lymphoblastoid cell line (LCL), called ZS, that originated spontaneously from the cultures of gamma‐irradiated (50 Gy) peripheral‐blood mononuclear cells of a normal donor. When injected subcutaneously in sublethally irradiated, splenectomized and anti‐asialo‐GM1‐treated nude mice, ZS cells invaded the lymph nodes, that appeared 10 to 50‐fold enlarged in all of the mice tested. Furthermore, ZS cells expressed a typical T‐cell surface structure, the CD2 molecule, detectable by a variety of different anti‐CD2 monoclonal antibodies (MAbs). However, other T‐cell markers were not found, with the possible exception of a truncated messenger of the β chain of the T‐cell receptor and ZS cells could be identified as B cells since they (i) expressed a battery of markers of the resting and activated B cells, (ii) displayed a monoclonal rearrangement of the lgH chain locus and (iii) synthesized lgM K molecules. The Epstein‐Barr virus (EBV) genome was detected in ZS cells in approximately ten copies per cell by DNA hybridization techniques. Furthermore, the cells were positive for EBV nuclear antigens (EBNA). Western blotting analysis of EBV encoded antigens demonstrated clear differences with those present in the B 95.8 virus‐producer cell line, indicating that ZS cells were not infected by EBV in vitro and that they already harbored the virus in vivo. ZS cells formed colonies in vitro with a high cloning efficiency and displayed chromosomal abnormalities in all of the mitoses (karyotype 47, xy, +13,–14, 8p+, 21p+, +m). In spite of these malignant features, ZS cells expressed the full range of EBV latent proteins as usually do “normal” LCSs and did not have any of the chromosomal abnormalities that juxtapose the c‐myc oncogene to one of the genes coding for immunoglobulir molecules.This publication has 50 references indexed in Scilit:
- Chemical carcinogen epstein-barr virus (ebv) synergism: Ebv genome amplification and site-specific mutation during transformationInternational Journal of Cancer, 1989
- Burkitt's lymphoma cell lines reveal different degrees of tumorigenicity in nude miceInternational Journal of Cancer, 1988
- Molecular Genetics of Human B Cell NeoplasiaPublished by Elsevier ,1986
- Different stages of B cell differentiation in non-T acute lymphoblastic leukemia.Journal of Clinical Investigation, 1984
- Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2.Proceedings of the National Academy of Sciences, 1984
- The Biology and Chemistry of Epstein-Barr VirusThe Journal of Infectious Diseases, 1982
- Interaction of Epstein-Barr virus with leukaemic B cellsin vitro. II. Cell line establishment from prolymphocytic leukaemia and from Waldenström's macroglobulinaemiaInternational Journal of Cancer, 1982
- Analysis of HLA-DR polymorphism by two-dimensional peptide mapping.Proceedings of the National Academy of Sciences, 1981
- Monoclonal antibodies identifying a novel T-Cell antigen and Ia antigens of human lymphocytesImmunogenetics, 1980
- Induction of Cellular DNA Synthesis in Human Leucocytes by Epstein–Barr VirusNature, 1971